Skip to content

multicenter study for treatment of colon cancer

multicenter study for treatment of colon cancer - multicenter study for treatment of colon cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000038707
Enrollment
12000
Registered
2019-11-30
Start date
1992-08-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Interventions

None listed

Sponsors

Yokohama city university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: the cases who had pathologically adenocarcinoma, and were undergone surgery.

Exclusion criteria

Exclusion criteria: judgement not to register suitably.

Design outcomes

Primary

MeasureTime frame
5-year overall survival rate of laparoscopic and open surgery for colon cancer

Secondary

MeasureTime frame
1.To investigate the comparison of 5-year disease free survival rate between laparoscopic surgery and open surgery. 2.To investigate the safety and effectivity for preoperative treatment (adverse event, completion rate, response rate, disease-free survival time, overall survival time, et al.) 3. To investigate the operative procedures, postoperative complication rates and the risk factors for postoperative complications. 4.To investigate the postoperative incisional hernia. 5. To investigate the effect of postoperative adjuvant chemotherapy. 6. To investigate the recurrence site and treatment after surgery. 7. To investigate the impact of postoperative complications for long-term outcomes. 8. To investigate the outcomes for the cases with clinical T4b(invasion to adjacent organs). 9. To investigate the outcomes for the cases with distant metastases (clinical Stage IV). 10.To investigate the surgical outcomes for the obesity cases(BMI, SFA, VFA) 11. To investigate the outcomes of laparoscopic surgery for elderly cases. 12. To investigate the outcomes for the cases with paraaortic lymph node dissection. 13. To investigate the outcomes for the cases with comorbidity(cardiac disease, pulmonary disease, antiplatelet therapy, anticoagulant therapy). 14. To investigate the effectiveness of lymph node dissection using lymph node dissection index. 15. Subgroup analysis: To analyze the above outcomes by tumor locations, pathological stages et al.

Countries

Japan

Contacts

Public ContactMidori Tominaga

Yokohama city university Y-NEXT

ynext@yokohama-cu.ac.jp0457872800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026